Bellevue Healthcare Trust plc (BBH) Ord GBP0.01

Sell:126.40pBuy:127.00p0.40p (0.31%)

FTSE All Share:0.55%
Market closed |
Prices delayed by at least 15 minutes
Sell:126.40p
Buy:127.00p
Change:0.40p (0.31%)
Market closed |
Prices delayed by at least 15 minutes
Sell:126.40p
Buy:127.00p
Change:0.40p (0.31%)
Market closed |
Prices delayed by at least 15 minutes

Trust Information

About this company

Bellevue Healthcare Trust plc is a United Kingdom-based investment trust. The investment objective of the Company is to provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company invests in a concentrated portfolio of listed or quoted equities in the global healthcare industry. The Company may also invest in American Depositary Receipts (ADRs), or convertible instruments issued by such companies and may invest in, or underwrite, future equity issues by such companies. Its portfolio includes Dental, Diagnostics, Diversified Therapeutics, Focused Therapeutics, Healthcare information technology, Healthcare Technology, Managed Care, Med-Tech, Generics, Services, Tools, Distributors, and others. The Company's investment manager is Bellevue Asset Management (UK) Limited.

Objective

The investment objective of the Company is to provide shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company’s specific return objective shall be for its NAV per share (on a total return basis) to beat the total return of the MSCI World Health Care Index (in sterling) on a rolling 3 year period (the index total return including dividends reinvested on a net basis)

Costs

  • Ongoing charge1.03%
  • Annual management charge0.95% of Market Cap
  • Performance feeNo

Fee structure

Management fee payable monthly in arrear and is at the rate of one-twelfth of 0.95% per calendar month of the Market Capitalisation.There is no performance fee payable to Bellevue. The agreement is terminable on 12 months notice.

Value Assessment

  • Value Assessment review date31 December 2024
  • Value Assessment next review date31 December 2025
  • Is Assessment of Value required under COLL?No
  • Outcome of COLL Assessment of Valuen/a
  • Outcome of PRIN Value Assessment or review-
  • Other review related to value and or chargesOther local requirements or procedures
  • Further information-
Click to see more

Key facts

  • Currency
    GBX
  • Benchmark
    MSCI World HealthCare TR GBP
  • Shares in issue
    225.67m
  • Gross gearing
    3.00%
  • EPIC
    BBH
  • ISIN
    GB00BZCNLL95
  • Domicile
    United Kingdom
  • Exchange
    London Stock Exchange (LON)
  • Index
    FTSE All Share Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview of the company, currency, shares in issue, EPIC, location, exchange, index, website, Data sourced by LSEG. Objective, Costs, Fee Structure, Key facts including Benchmark, Gross gearing are provided by MorningStar.